Table 2.
Age | Income | Education | BMI | Stage At Diagnosis | Time Since Diagnosis | Total Comorbidities | Menopausal Status | Treatment Type | |
---|---|---|---|---|---|---|---|---|---|
Baseline | |||||||||
AvgMVPA | −0.23** | 0.15** | 0.21** | −0.31** | −0.11* | 0.09 | −0.30** | −0.18** | −0.00 |
EXSE | −0.04 | 0.16** | 0.10 | −0.34** | −0.14** | 0.03 | −0.33** | −0.03 | 0.06 |
BARSE | 0.03 | −0.11* | 0.05 | −0.26** | −0.04 | 0.01 | −0.24** | 0.01 | 0.07 |
PSW | 0.07 | 0.14** | 0.16** | −0.42** | −0.04 | 0.03 | −0.35** | 0.00 | −0.03 |
GSE | 0.14** | 0.14** | 0.04 | −0.16** | −0.12* | 0.07 | −0.20** | −0.20** | 0.02 |
6 months | |||||||||
AvgMVPA | −0.19** | 0.11* | 0.19** | −0.22** | −0.12* | 0.07 | −0.27** | −0.08 | 0.03 |
EXSE | 0.03 | 0.07 | 0.12* | −0.29** | −0.13* | 0.09 | −0.32** | 0.03 | 0.09 |
BARSE | 0.03 | 0.11 | 0.09 | −0.28** | −0.10 | 0.08 | −0.31** | 0.05 | 0.09 |
PSW | 0.08 | 0.11 | 0.07 | −0.36** | −0.12* | 0.07 | −0.34** | 0.00 | 0.09 |
GSE | 0.12* | 0.11* | 0.07 | −0.12* | −0.09 | 0.05 | −0.18** | 0.01 | 0.11* |
indicates significance at p<0.05;
indicates significance at p<0.01;
AvgMVPA, average daily minutes of moderate to vigorous physical activity; EXSE, exercise self-efficacy; BARSE, barrier self-efficacy; PSW, physical self-worth; GSE, global self-esteem; treatment type, 1=surgery + chemo + radiation, 2=surgery + chemo, 3=surgery + radiation, 4=surgery only, 5=other